含糊 发表于 2025-3-23 12:43:25

Submitted on: 26 December 2007.
Revised on: 10 March 2008.
Accepted on: 18 April 2008.

___________________JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Accessible 发表于 2025-3-23 16:04:42

Submitted on: 20 October 2022.
Revised on: 18 November 2022.
Accepted on: 15 December 2022.

___________________JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

agnostic 发表于 2025-3-23 19:11:29

http://reply.papertrans.cn/2/158/15709/15709-13.png

朝圣者 发表于 2025-3-24 00:47:53

Submitted on: 17 May 2022.
Revised on: 05 July 2022.
Accepted on: 19 August 2022.

___________________JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

弯腰 发表于 2025-3-24 06:10:25

Submitted on: 20 February 2021.
Revised on: 01 June 2021.
Accepted on: 16 July 2021.

___________________JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

性满足 发表于 2025-3-24 06:43:15

http://reply.papertrans.cn/2/158/15709/15709-16.png

LASH 发表于 2025-3-24 13:32:07

Submitted on: 01 May 2013.
Revised on: 19 July 2013.
Accepted on: 11 August 2013.

___________________JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

大猩猩 发表于 2025-3-24 18:24:32

http://reply.papertrans.cn/2/158/15709/15709-18.png

indignant 发表于 2025-3-24 20:12:34

Submitted on: 28 February 2010.
Revised on: 14 June 2010.
Accepted on: 27 July 2010.

___________________JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

广告 发表于 2025-3-25 02:40:47

http://reply.papertrans.cn/2/158/15709/15709-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊JOURNAL OF CARDIOVASCULAR PHARMACOLOGY 2024/2025影响因子:2.673 (J CARDIOVASC PHARM) (0160-2446). (PHARMACOLOGY & PHAR